1. Neuroprotective Effect of Hydroxytyrosol in Experimental Diabetic Retinopathy: Relationship with Cardiovascular Biomarkers
- Author
-
Junta de Andalucía, González-Correa, José Antonio, Rodríguez-Pérez, María Dolores, Márquez-Estrada, L., López-Villodres, J.A., Reyes, J.J., Rodríguez-Gutiérrez, Guillermo, Fernández-Bolaños Guzmán, Juan, Cruz, José Pedro de la, Junta de Andalucía, González-Correa, José Antonio, Rodríguez-Pérez, María Dolores, Márquez-Estrada, L., López-Villodres, J.A., Reyes, J.J., Rodríguez-Gutiérrez, Guillermo, Fernández-Bolaños Guzmán, Juan, and Cruz, José Pedro de la
- Abstract
The aim of the study was to test the neuroprotective effect of hydroxytyrosol (HT) on experimental diabetic retinopathy. Animals were divided in four groups: (1) control nondiabetic rats, (2) streptozotocin-diabetic rats (DR), (3) DR treated with 1 mg/kg/day p.o. HT, and (4) DR treated with 5 mg/kg/day p.o. HT. Treatment with HT was started 7 days before inducing diabetes and was maintained for 2 months. In the DR group, total area occupied by extracellular matrix was increased, area occupied by retinal cells was decreased; both returned to near-control values in DR rats treated with HT. The number of retinal ganglion cells in DR was significantly lower (44%) than in the control group, and this decrease was smaller after HT treatment (34% and 9.1%). Linear regression analysis showed that prostacyclin, platelet aggregation, peroxynitrites, and the dose of 5 mg/kg/day HT significantly influenced retinal ganglion cell count. In conclusion, HT exerted a neuroprotective effect on diabetic retinopathy, and this effect correlated significantly with changes in some cardiovascular biomarkers.
- Published
- 2018